by Elena Iemma | Nov 2, 2023 | Thinking Out Loud -Blog
See you in Munich… or Amsterdam! Before we get to the scary stuff, have you registered for the 9th annual Amsterdam Immunogenicity and Tolerance Seminar yet? We have an amazing line up of talks planned (see details here). A range of speakers from Cardiff and the...
by Riley Nolan | Oct 17, 2022 | Events, Featured
We had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below! Talks: Anne De Groot, M.D., EpiVax, Inc. Deimmunization and...
by Riley Nolan | Sep 12, 2022 | Featured, News
PROVIDENCE, RI, September 12, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk...
by Riley Nolan | Nov 4, 2021 | Featured, News
PROVIDENCE, RI, November 4, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce an important commercial licensing agreement with Maruho Co., Ltd. (“Maruho”) for EpiVax’s patented Tregitope technology. This marks an exciting step for Maruho and...
by Riley Nolan | Aug 31, 2021 | Featured, Thinking Out Loud -Blog
From Disco to BTS Time flies when you are having fun! I totally missed the 10th anniversary of “Thinking Out Loud” a.k.a TOL – this newsletter. Do you want to see the first post? I hope you like disco! Lucky for you, I’ve moved on...